BRD9 controls the oxytocin signaling pathway in gastric cancer via CANA2D4, CALML6, GNAO1, and KCNJ5.

导出 OA

翻译打印收藏纠错

作者： Yuan,Wang ^[1] ; Xue-Yan,Jiang ^[1] ; Xi-Yong,Yu ^[1]

作者单位： Key Laboratory of Molecular Target and Clinical Pharmacology, School of Pharmaceutical Sciences and the Affiliated Fifth Hospital, Guangzhou Medical University, Guangzhou 511436, China. ^[1]

关键词 BI9564 Bromodomain-containing protein 9 (BRD9)MGC-803 cells calcium voltage-gated channel auxiliary subunit alpha2 delta 4 (CANA2D4)calmodulin-like 6 (CALML6)combination therapy

DOI 10.21037/tcr.2020.03.67

PMID 35117701

发布时间 2022-05-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Translational cancer research

2020年9卷5期

3354-3366页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

BRD9 controls the oxytocin signaling pathway in gastric cancer via CANA2D4, CALML6, GNAO1, and KCNJ5.

Translational cancer research

相似文献

Translational cancer research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

BRD9 controls the oxytocin signaling pathway in gastric cancer via CANA2D4, CALML6, GNAO1, and KCNJ5.

Translational cancer research

相似文献

Translational cancer research

相关期刊

检索历史清除